Concord Medical Services, which leases radiotherapy and diagnostic imaging equipment to cancer centers in China, will see its quiet period end next Wednesday, Jan. 20. On Dec. 11, 2009, the company raised $132 million by offering 12 million shares at $11,...read more
Eight deals were originally slated to begin trading this week in what would have been, if all had priced, the busiest IPO week of the year. However, only four of the eight ultimately made it to market, reflecting subdued deal demand and investors' lingering...read more
Concord Medical Services, which leases radiotherapy and diagnostic imaging equipment to cancer centers in China, raised $132 million by offering 12,000,000 shares at $11.00, within the range of $9.50 to $11.50. Concord Medical Services plans to list on the NYSE...read more
This week, three profitable Chinese companies will attempt to take advantage of the recent interest and confidence investors have shown in the IPO markets: a solar module provider, a cancer center operator and a biopharmaceutical company will all come to market...read more
Concord Medical quiet period ends January 20
Concord Medical Services, which leases radiotherapy and diagnostic imaging equipment to cancer centers in China, will see its quiet period end next Wednesday, Jan. 20. On Dec. 11, 2009, the company raised $132 million by offering 12 million shares at $11,...read more
Four of eight planned IPOs this week complete deals
Eight deals were originally slated to begin trading this week in what would have been, if all had priced, the busiest IPO week of the year. However, only four of the eight ultimately made it to market, reflecting subdued deal demand and investors' lingering...read more
Concord prices IPO at $11.00, within the range
Concord Medical Services, which leases radiotherapy and diagnostic imaging equipment to cancer centers in China, raised $132 million by offering 12,000,000 shares at $11.00, within the range of $9.50 to $11.50. Concord Medical Services plans to list on the NYSE...read more
Three Chinese IPOs expected to debut this week
This week, three profitable Chinese companies will attempt to take advantage of the recent interest and confidence investors have shown in the IPO markets: a solar module provider, a cancer center operator and a biopharmaceutical company will all come to market...read more